Intended for healthcare professionals

  1. Research
  2. Effect of oral...
  3. Effect of oral nimodipine on cerebral infarction and outcome after subarachnoid haemorrhage: British aneurysm nimodipine trial.
Research Article

Effect of oral nimodipine on cerebral infarction and outcome after subarachnoid haemorrhage: British aneurysm nimodipine trial.

British Medical Journal 1989; 298 doi: https://doi.org/10.1136/bmj.298.6674.636 (Published 11 March 1989) Cite this as: British Medical Journal 1989;298:636

Related articles

See more

Cited by...

  • Safety and efficacy of glibenclamide on cerebral oedema following aneurysmal subarachnoid haemorrhage: a randomised, double-blind, placebo-controlled clinical trial
  • Blood oxygenation-level dependent cerebrovascular reactivity imaging as strategy to monitor CSF-hemoglobin toxicity
  • Reliability of the Diagnosis of Cerebral Vasospasm Using Catheter Cerebral Angiography: A Systematic Review and Inter- and Intraobserver Study
  • The fragility index in randomised controlled trials of interventions for aneurysmal subarachnoid haemorrhage: a systematic review
  • Neuromonitoring with near-infrared spectroscopy (NIRS) in aneurysmal subarachnoid haemorrhage: a systematic review protocol
  • Phase dynamics of cerebral blood flow in subarachnoid haemorrhage in response to sodium nitrite infusion
  • Study protocol for SFX-01 after subarachnoid haemorrhage (SAS): a multicentre randomised double-blinded, placebo controlled trial
  • Outcome of Oral and Intra-arterial Nimodipine Administration After Aneurysmal Subarachnoid Haemorrhage - A Single-centre Study
  • Academic neurosurgery in the UK: present and future directions
  • Management of Subarachnoid Hemorrhage
  • Apolipoprotein E mimetic peptide CN-105 improves outcome in a murine model of SAH
  • Nimodipine for the treatment of otolaryngic indications
  • Severity of cerebral vasospasm associated with development of collaterals following aneurysmal subarachnoid hemorrhage
  • Development and validation of outcome prediction models for aneurysmal subarachnoid haemorrhage: the SAHIT multinational cohort study
  • Predictors of Outcome in Aneurysmal Subarachnoid Hemorrhage Patients: Observations From a Multicenter Data Set
  • Effect of heparin on secondary brain injury in patients with subarachnoid hemorrhage: an additional 'H therapy in vasospasm treatment
  • Randomized, Open-Label, Phase 1/2a Study to Determine the Maximum Tolerated Dose of Intraventricular Sustained Release Nimodipine for Subarachnoid Hemorrhage (NEWTON [Nimodipine Microparticles to Enhance Recovery While Reducing Toxicity After Subarachnoid Hemorrhage])
  • Treatment of cerebral vasospasm with self-expandable retrievable stents: proof of concept
  • Cerebral vasospasm patterns following aneurysmal subarachnoid hemorrhage: an angiographic study comparing coils with clips
  • Hypoxemia associated with nimodipine in a patient with an aneurysmal subarachnoid hemorrhage
  • Delayed Cerebral Ischemia in Aneurysmal Subarachnoid Hemorrhage: Proposal of an Evidence-Based Combined Clinical and Imaging Reference Standard
  • The pathophysiology and treatment of delayed cerebral ischaemia following subarachnoid haemorrhage
  • Off-Label Use of Drugs and Devices in the Neuroendovascular Suite
  • Preconditioning the Human Brain: Proving the Principle in Subarachnoid Hemorrhage
  • Electrochemical Failure of the Brain Cortex Is More Deleterious When it Is Accompanied by Low Perfusion
  • Attributing Hypodensities on CT to Angiographic Vasospasm Is Not Sensitive and Unreliable
  • Definition of Delayed Cerebral Ischemia After Aneurysmal Subarachnoid Hemorrhage as an Outcome Event in Clinical Trials and Observational Studies: Proposal of a Multidisciplinary Research Group
  • Neuroprotection in Subarachnoid Hemorrhage
  • Sample Size Estimates for Clinical Trials of Vasospasm in Subarachnoid Hemorrhage
  • Intra-Arterial Nicardipine Infusion Improves CT Perfusion-Measured Cerebral Blood Flow in Patients with Subarachnoid Hemorrhage-Induced Vasospasm
  • Clazosentan to Overcome Neurological Ischemia and Infarction Occurring After Subarachnoid Hemorrhage (CONSCIOUS-1): Randomized, Double-Blind, Placebo-Controlled Phase 2 Dose-Finding Trial
  • Neurosurgery and pregnancy
  • Endothelial Nitric Oxide Synthase Polymorphism (-786T->C) and Increased Risk of Angiographic Vasospasm After Aneurysmal Subarachnoid Hemorrhage
  • Milrinone for the Treatment of Cerebral Vasospasm After Aneurysmal Subarachnoid Hemorrhage
  • Subtype Activation and Interaction of Protein Kinase C and Mitogen-Activated Protein Kinase Controlling Receptor Expression in Cerebral Arteries and Microvessels After Subarachnoid Hemorrhage
  • Effects of Acute Pravastatin Treatment on Intensity of Rescue Therapy, Length of Inpatient Stay, and 6-Month Outcome in Patients After Aneurysmal Subarachnoid Hemorrhage
  • Safety and Feasibility of Intra-Arterial Nicardipine for the Treatment of Subarachnoid Hemorrhage-Associated Vasospasm: Initial Clinical Experience with High-Dose Infusions
  • Effect of Nicardipine Prolonged-Release Implants on Cerebral Vasospasm and Clinical Outcome After Severe Aneurysmal Subarachnoid Hemorrhage: A Prospective, Randomized, Double-Blind Phase IIa Study
  • Effects of Acute Treatment With Pravastatin on Cerebral Vasospasm, Autoregulation, and Delayed Ischemic Deficits After Aneurysmal Subarachnoid Hemorrhage: A Phase II Randomized Placebo-Controlled Trial
  • Plasminogen Activator Inhibitor-1 4G Allele in the 4G/5G Promoter Polymorphism Increases the Occurrence of Cerebral Ischemia After Aneurysmal Subarachnoid Hemorrhage
  • Inflammatory Cell Adhesion Molecules in Ischemic Cerebrovascular Disease
  • Direct Costs of Modern Treatment of Aneurysmal Subarachnoid Hemorrhage in the First Year After Diagnosis
  • Quality of randomised controlled trials in head injury
Back to top